Your Article Summary
Secretory Leukocyte Protease Inhibitor and Helicobacter pylori in the Gastrointestinal Tract of HIV-infected Persons: A Review
The Internet Journal of Gastroenterology, 07/02/09
Chattopadhyay A et al. - Prevalence/incidence of Helicobater pylori (Hp) is reduced in HIV/AIDS. HIV-infection may alter the prevalence/incidence or pathology of Helicobacter pylori (Hp) infection. Secretory leukocyte protease inhibitor (SLPI) is an important broad spectrum innate immunity component that has anti-bacterial and HIV-1 inhibitory activity in different mucosal secretions and possibly in the local mucosal tissue milieu.
Related Articles
Effectiveness of Increasing Emergency Department Patients' Self-perceived Risk for Being Human Immunodeficiency Virus (HIV) Infected Through Audio Computer Self-interview–based Feedback About Reported HIV Risk Behaviors
Academic Emergency Medicine, 11/11/09
Relevance Score: 95%
HIV-Specific Health Care Utilization and Mortality among Tuberculosis/HIV Coinfected Persons
AIDS Patient Care and STDs, 10/06/09
Relevance Score: 95%
Mediators of HIV-related stigma and risk behavior in HIV infected young women
AIDS Care, 11/12/09
Relevance Score: 94%
Sperm May Play Leading Role In Spreading HIV
ScienceDaily, 10/27/09
Relevance Score: 94%
Female sex work and HIV risks in Croatia
AIDS Care, 10/29/09
Relevance Score: 93%
Today in GI Infectious Disease...keeping you current
Receive free subspecialty "5-minute updates" via email
Hydrogel protection: a novel approach to reduce bowel inflammation in experimental gastroschisis
European Journal of Obstetrics & Gynecology and Reproductive Biology , 12/18/09
Correlation of Pancreatic Histopathologic Findings and Islet Yield in Children With Chronic Pancreatitis Undergoing Total Pancreatectomy and Islet Autotransplantation
Pancreas, 12/17/09
Significance of Renal Rim Grade on Computed Tomography in Severity Evaluation of Acute Pancreatitis
Pancreas, 12/17/09

See Latest Articles